Found: 43
Select item for more details and to access through your institution.
Pediatric Mesangial Proliferative Glomerulonephritis Has Increased the Platelet Thrombus Formation Potentials under High-Shear Flow Condition.
- Published in:
- Nephron, 2024, v. 148, n. 6, p. 415, doi. 10.1159/000534494
- By:
- Publication type:
- Article
Force‐sensing treadmill gait analysis system can detect gait abnormalities in haemophilia patients without arthropathy.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 780, doi. 10.1111/hae.14987
- By:
- Publication type:
- Article
Emicizumab-mediated hemostatic function assessed by thrombin generation assay in an in vitro model of factor VIII-depleted thrombophilia plasma.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 2, p. 109, doi. 10.1007/s12185-023-03683-y
- By:
- Publication type:
- Article
Anticoagulant effects of protein C, protein S, and antithrombin levels on the protein C pathway in young children.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 2, p. 196, doi. 10.1007/s12185-023-03699-4
- By:
- Publication type:
- Article
Hybrid human‐porcine factor VIII proteins partially escape the inhibitory effects of anti‐factor VIII inhibitor alloantibodies having A2 or C2 domain specificity.
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 140, doi. 10.1111/hae.14911
- By:
- Publication type:
- Article
Coagulation potentials of plasma‐derived factors VIIa and X mixture (Byclot<sup>®</sup>) evaluated by global coagulation assay in patients with acquired haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 249, doi. 10.1111/hae.14902
- By:
- Publication type:
- Article
Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow.
- Published in:
- Thrombosis Journal, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12959-023-00569-1
- By:
- Publication type:
- Article
Longitudinal dynamic changes in factor VIII inhibitor titers in patients with hemophilia A and inhibitors receiving emicizumab prophylaxis.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 6, p. 690, doi. 10.1007/s12185-023-03667-y
- By:
- Publication type:
- Article
Coagulant potentials of emicizumab in the plasmas from infant and toddler patients with hemophilia A.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 10, p. 1, doi. 10.1002/pbc.30590
- By:
- Publication type:
- Article
Intra‐articular haemorrhage caused by reduced recovery of PEGylated recombinant factor VIII due to an anti‐PEG antibody developed after mRNA‐1273 SARS‐CoV‐2 vaccination in haemophilia A.
- Published in:
- Haemophilia, 2023, v. 29, n. 3, p. 935, doi. 10.1111/hae.14786
- By:
- Publication type:
- Article
High levels of factor VIII activity in patients with acquired hemophilia A in remission are associated with unusually low coagulation potentials.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 5, p. 669, doi. 10.1007/s12185-022-03528-0
- By:
- Publication type:
- Article
Two pediatric cases of severe hemophilia A in which emicizumab prophylaxis failed to prevent traumatic extra-articular hemorrhage.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 4, p. 607, doi. 10.1007/s12185-022-03490-x
- By:
- Publication type:
- Article
Comprehensive genetic screening for vascular Ehlers–Danlos syndrome through an amplification‐based next‐generation sequencing system.
- Published in:
- American Journal of Medical Genetics. Part A, 2023, v. 191, n. 1, p. 37, doi. 10.1002/ajmg.a.62982
- By:
- Publication type:
- Article
Anti‐idiotype monoclonal antibodies against emicizumab enable accurate procoagulant and anticoagulant assays, irrespective of the test base, in the presence of emicizumab.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 329, doi. 10.1111/hae.14662
- By:
- Publication type:
- Article
Modified expi293 cell culture system using piggyBac transposon enables efficient production of human FVIII.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 1, p. 56, doi. 10.1007/s12185-022-03468-9
- By:
- Publication type:
- Article
First case report of hematidrosis complicated with type 1 von Willebrand disease.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Activated partial thromboplastin time-based clot waveform analysis enables measurement of very low levels of factor IX activity in patients with severe hemophilia B.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Emicizumab enhances thrombus formation in vitro under high shear flow conditions in whole blood from patients with type 1 and type 3 von Willebrand disease.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 694, doi. 10.1111/hae.14581
- By:
- Publication type:
- Article
A case of a young boy with hyper-fibrinolysis associated with natural fibrin precipitates suspected to have occurred through a novel coagulation and fibrinolysis mechanism.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Screening of the protein C pathway abnormality‐related thrombophilia by using thrombomodulin‐mediated tissue factor‐triggered clot waveform analysis.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 100, doi. 10.1111/ejh.13777
- By:
- Publication type:
- Article
Comprehensive coagulation and fibrinolytic potential in the acute phase of pediatric patients with idiopathic nephrotic syndrome evaluated by whole blood-based rotational thromboelastometry.
- Published in:
- Pediatric Nephrology, 2022, v. 37, n. 7, p. 1605, doi. 10.1007/s00467-021-05366-4
- By:
- Publication type:
- Article
The balance of comprehensive coagulation and fibrinolytic potential is disrupted in patients with moderate to severe COVID-19.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 6, p. 826, doi. 10.1007/s12185-022-03308-w
- By:
- Publication type:
- Article
Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 4, p. 489, doi. 10.1007/s12185-021-03276-7
- By:
- Publication type:
- Article
Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 2, p. 163, doi. 10.1007/s12185-021-03249-w
- By:
- Publication type:
- Article
A microchip flow‐chamber assay screens congenital primary hemostasis disorders.
- Published in:
- Pediatrics International, 2021, v. 63, n. 2, p. 160, doi. 10.1111/ped.14378
- By:
- Publication type:
- Article
A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X.
- Published in:
- International Journal of Hematology, 2020, v. 112, n. 5, p. 621, doi. 10.1007/s12185-020-02959-x
- By:
- Publication type:
- Article
Emicizumab improves the stability and structure of fibrin clot derived from factor VIII‐deficient plasma, similar to the addition of factor VIII.
- Published in:
- Haemophilia, 2020, v. 26, n. 3, p. e97, doi. 10.1111/hae.13961
- By:
- Publication type:
- Article
Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A novel simultaneous clot‐fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 4, p. 518, doi. 10.1111/bjh.16111
- By:
- Publication type:
- Article
Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hemostatic function in hyperfibrinolytic disseminated intravascular coagulation.
- Published in:
- Pediatrics International, 2019, v. 61, n. 9, p. 872, doi. 10.1111/ped.13919
- By:
- Publication type:
- Article
Hemostatic assessment of combined anticoagulant therapy using warfarin and prothrombin complex concentrates in a case of severe protein C deficiency.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Whole blood ristocetin‐induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease.
- Published in:
- Haemophilia, 2019, v. 25, n. 3, p. e174, doi. 10.1111/hae.13725
- By:
- Publication type:
- Article
Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Continuous infusions of B domain-truncated recombinant factor VIII, turoctocog alfa, for orthopedic surgery in severe hemophilia A: first case report.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Factor (F)VIII/VIIa enhances global haemostatic function in the co-presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 528, doi. 10.1111/bjh.15209
- By:
- Publication type:
- Article
First report of real-time monitoring of coagulation function potential and IgG subtype of anti-FVIII autoantibodies in a child with acquired hemophilia A associated with streptococcal infection and amoxicillin.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Use of a microchip flow-chamber system as a screening test for platelet storage pool disease.
- Published in:
- International Journal of Hematology, 2015, v. 102, n. 2, p. 157, doi. 10.1007/s12185-015-1819-8
- By:
- Publication type:
- Article
Tissue factor pathway inhibitor in activated prothrombin complex concentrates (aPCC) moderates the effectiveness of therapy in some severe hemophilia A patients with inhibitor.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 5, p. 577, doi. 10.1007/s12185-014-1572-4
- By:
- Publication type:
- Article
Hemostatic Treatment Using Factor VIII Concentrates for Neutralizing High-Responding Inhibitors Prior to CVAD Insertion for Immune-Tolerance Induction Therapy.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2012, v. 18, n. 1, p. 66, doi. 10.1177/1076029611412364
- By:
- Publication type:
- Article
Correlations between global clotting function tests, duration of operation, and postoperative chest tube drainage in pediatric cardiac surgery.
- Published in:
- Pediatric Anesthesia, 2011, v. 21, n. 8, p. 865, doi. 10.1111/j.1460-9592.2011.03524.x
- By:
- Publication type:
- Article
A modified thrombin generation test for investigating very low levels of factor VIII activity in hemophilia A.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 3, p. 409, doi. 10.1111/j.1365-2141.2008.07366.x
- By:
- Publication type:
- Article